Generic Viagra (Sildenafil) Pills

The physiologic mechanism of erection of the penis involves release of nitric oxide (NO) in the corpus cavernosum during sexual stimulation. NO then activates the enzyme guanylate cyclase, which results in increased levels of cyclic guanosine monophosphate (cGMP), producing smooth muscle relaxation in the corpus cavernosum and allowing inflow of blood. Sildenafil has no direct relaxant effect on isolated human corpus cavernosum, but enhances the effect of nitric oxide (NO) by inhibiting phosphodiesterase type 5 (PDE5), which is responsible for degradation of cGMP in the corpus cavernosum. When sexual stimulation causes local release of NO, inhibition of PDE5 by sildenafil causes increased levels of cGMP in the corpus cavernosum, resulting in smooth muscle relaxation and inflow of blood to the corpus cavernosum. Sildenafil at recommended doses has no effect in the absence of sexual stimulation.

Studies in vitro have shown that sildenafil is selective for PDE5. Its effect is more potent on PDE5 than on other known phosphodiesterases (10-fold for PDE6, > 80-fold for PDE1, > 700-fold for PDE2, PDE3, PDE4, PDE7, PDE8, PDE9, PDE10, and PDE11). The approximately 4,000-fold selectivity for PDE5 versus PDE3 is important because PDE3 is involved in control of cardiac contractility. Sildenafil is only about 10-fold as potent for PDE5 compared to PDE6, an enzyme found in the retina which is involved in the phototransduction pathway of the retina. This lower selectivity is thought to be the basis for abnormalities related to color vision observed with higher doses or plasma levels.

Dehydration, if severe enough, can be life-threatening. While the obvious solution is to drink fluids, drinking even a little bit can sometimes make vomiting or nausea worse.

If you can’t keep a small amount of water down, you should see a doctor as soon as possible.

The U.S. National Library of Medicine lists these warning signs of dehydration:
Dryness or a sticky feeling in the mouth.
Urine that is a dark yellow color.
Not urinating as much as usual or not at all.
Inability to produce tears.
Eyes that appear sunken.
When the “soft spot” at the top of a baby’s head appears sunken.
Feeling tired or having no energy.

Everyone has a certain amount of stress. But too much of it may make us feel quite fearful or worried, not to mention the physical effects it can cause, such as a rise in blood pressure.

The National Women’s Health Information Center offers this list of warning signs that you may be stressed out:
Insomnia.
Diarrhea, constipation, bloating, irritable bowel syndrome or stomach cramps.
Feeling tense, irritable, anxious, sad, angry or depressed.
Difficulty paying attention or feeling like you don’t have any energy.
Significant changes in eating habits or body weight.
Skin reactions, including hives.
Increased symptoms associated with diabetes, asthma or arthritis.
A rise in blood pressure.
Decreased sexual desire.
Pain in the back or neck.

Shedding some excess weight through diet, exercise or surgery may help obese adults with kidney disease ward off further decline in kidney function, research hints.

The kidneys filter waste products from the blood and excrete them in the urine. When damaged, their ability to perform these vital functions is reduced.

More than a third of US adults are either overweight or obese, putting them at increased risk for kidney trouble, not to mention heart trouble and diabetes. Weight loss has been shown to improve control of diabetes, lower blood pressure and cholesterol levels, and reduce the effects of heart disease.

To see if losing weight might also help protect the kidneys, Dr. Sankar Navaneethan, from Ohio’s Cleveland Clinic, and colleagues pooled data from 13 studies that examined the impact on kidney function of weight loss achieved through diet, exercise, or surgery. They report their findings in an upcoming issue of the Clinical Journal of the American Society Nephrology.

The researchers found that, in obese adults with kidney disease, losing weight through diet and exercise reduced one hallmark of kidney damage - namely, excess excretion of protein in the urine - what doctors call “proteinuria.”

Diet- and exercise-induced weight loss may also prevent additional decline in kidney function in obese adults with kidney disease, the researchers found.

Weight loss achieved through surgery, on the other hand, seems to help normalize the rate at which the kidneys filter waste products in obese adults with abnormally high filtration rates - a well-known risk factor for the development of kidney disease.

Currently more than 20 million Americans have chronic kidney disease and it’s estimated that by 2015 there will be more than 700,000 people with the most advanced form of kidney disease known as end-stage renal disease or ESRD.

“The health care costs that are associated with this increase are staggering,” Navaneethan and colleagues note.

In obese adults, weight loss may offer real benefits in terms of the kidneys, in addition to the heart-related benefits of shedding excess pounds, they conclude.

Men taking the antiviral drugs peginterferon and ribavirin for chronic hepatitis C virus infection often experience sexual dysfunction, results of a study indicate.

This drug combination, which is standard therapy for chronic hepatitis C, has the potential to impact all three components of sexual health: desire, function and satisfaction, the researchers found.

“Men planning to receive peginterferon and ribavirin should be counseled about the possibility of a decline in sexual health during treatment and receive adequate support if these side effects occur,” Dr. Lorna M. Dove of New York Presbyterian Medical Center and colleagues suggest in the journal Gastroenterology.

Hepatitis C is a blood-borne infectious disease that is often without symptoms and can cause inflammation of the liver, cirrhosis, and in extreme cases, liver cancer. It is usually contracted through transfusions of unscreened blood, or by injecting or inhaling drugs.

Chronic hepatitis C affects 1 percent to 2 percent of the American population and is more common among African Americans than Caucasian Americans and other racial and ethnic groups in the U.S.

The sexual health of men with chronic hepatitis C before, during, and after combination therapy has not been well studied, Dove and colleagues note.

The current study shows that impairments in sexual function and desire are common side effects of this therapy in men, and these effects are not always completely reversed after therapy is stopped.

As part of a large study, 260 men treated with peginterferon and ribavirin completed questionnaires about sexual health before, during and after therapy.

Prior to treatment, 37 percent reported mild impairment in their sex drive, 26 percent reported erectile dysfunction, 22 percent reported ejaculation trouble, and 44 percent reported dissatisfaction with their sex life.

By the end of therapy at either 24 or 48 weeks, 38 percent to 48 percent of men reported that their lower sexual function was worse than before treatment. African American men reported less impairment overall than Caucasian American men during treatment.

For patients who stopped therapy at 24 weeks, sexual health returned to near normal within 6 months of the end of treatment, the researchers found.

Relative to before treatment, men receiving treatment for 48 weeks reported higher erectile and ejaculation problems, although persistent erectile impairment was limited to Caucasian American men.